BNP Paribas Discount Zert MRNA 30.../ DE000PZ0ULF5 /
05/08/2024 17:20:44 | Chg.-1.090 | Bid17:30:47 | Ask17:30:47 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
59.730EUR | -1.79% | 60.060 Bid Size: 1,800 |
60.160 Ask Size: 1,800 |
Moderna Inc | - USD | 30/12/2024 | Call |
GlobeNewswire
13/06
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - ...
GlobeNewswire
05/06
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - ...
GlobeNewswire
22/05
Oruka Therapeutics Expands Leadership Team with Appointment of Industry Veterans Drs. Joseph Senn an...
GlobeNewswire
12/05
TrialWire Patient Recruitment Platform that Reboots Stalled Clinical Trials announced as Multi-Award...
GlobeNewswire
08/05
CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
08/05
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...
GlobeNewswire
02/05
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
01/05
Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems